The antiparasitic drug niclosamide inhibits dengue virus infection by interfering with endosomal acidification independent of mTOR

Jo Chi Kao, Wei Chun HuangFu, Tsung Ting Tsai, Min Ru Ho, Ming Kai Jhan, Ting Jing Shen, Po Chun Tseng, Yung Ting Wang, Chiou Feng Lin

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Background: The antiparasitic agent niclosamide has been demonstrated to inhibit the arthropod-borne Zika virus. Here, we investigated the antiviral capacity of niclosamide against dengue virus (DENV) serotype 2 infection in vitro and in vivo. Principle finding: Niclosamide effectively retarded DENV-induced infection in vitro in human adenocarcinoma cells (A549), mouse neuroblastoma cells (Neuro-2a), and baby hamster kidney fibroblasts (BHK-21). Treatment with niclosamide did not retard the endocytosis of DENV while niclosamide was unable to enhance the antiviral type I interferon response. Furthermore, niclosamide did not cause a direct effect on viral replicon-based expression. Niclosamide has been reported to competitively inhibit the mTOR (mammalian target of rapamycin), STAT3 (signal transducer and activator of transcription 3), and NF-κB (nuclear factor kappa-light-chain-enhancer of activated B cells) signaling pathways; however, selective inhibitors of those pathways did not reduce DENV infection. Similar to the vacuolar-type H+-ATPase inhibitor bafilomycin A1, both niclosamide and other protonophores, such as CCCP (carbonyl cyanide m-chlorophenyl hydrazone), and FCCP (carbonyl cyanide-p-trifluoromethoxyphenylhydrazone), effectively reduced endosomal acidification and viral dsRNA replication. Co-administration of a single dose of niclosamide partially decreased viral replication, viral encephalitis, and mortality in DENV-infected ICR suckling mice. Significance: These results demonstrate that niclosamide diminishes viral infection by hindering endosomal acidification.

Original languageEnglish
Article numbere0006715
JournalPLoS Neglected Tropical Diseases
Volume12
Issue number8
DOIs
Publication statusPublished - Aug 1 2018

Fingerprint

Niclosamide
Antiparasitic Agents
Dengue Virus
Virus Diseases
Sirolimus
Carbonyl Cyanide m-Chlorophenyl Hydrazone
Carbonyl Cyanide p-Trifluoromethoxyphenylhydrazone
Antiviral Agents
Viral Encephalitis
Vacuolar Proton-Translocating ATPases
Arboviruses
STAT3 Transcription Factor
Inbred ICR Mouse
Interferon Type I
Replicon
NF-kappa B
Endocytosis
Neuroblastoma
Cricetinae
Adenocarcinoma

ASJC Scopus subject areas

  • Public Health, Environmental and Occupational Health
  • Infectious Diseases

Cite this

The antiparasitic drug niclosamide inhibits dengue virus infection by interfering with endosomal acidification independent of mTOR. / Kao, Jo Chi; HuangFu, Wei Chun; Tsai, Tsung Ting; Ho, Min Ru; Jhan, Ming Kai; Shen, Ting Jing; Tseng, Po Chun; Wang, Yung Ting; Lin, Chiou Feng.

In: PLoS Neglected Tropical Diseases, Vol. 12, No. 8, e0006715, 01.08.2018.

Research output: Contribution to journalArticle

Kao, Jo Chi ; HuangFu, Wei Chun ; Tsai, Tsung Ting ; Ho, Min Ru ; Jhan, Ming Kai ; Shen, Ting Jing ; Tseng, Po Chun ; Wang, Yung Ting ; Lin, Chiou Feng. / The antiparasitic drug niclosamide inhibits dengue virus infection by interfering with endosomal acidification independent of mTOR. In: PLoS Neglected Tropical Diseases. 2018 ; Vol. 12, No. 8.
@article{f1ae944fe8004338a5c6aa7186eb9eea,
title = "The antiparasitic drug niclosamide inhibits dengue virus infection by interfering with endosomal acidification independent of mTOR",
abstract = "Background: The antiparasitic agent niclosamide has been demonstrated to inhibit the arthropod-borne Zika virus. Here, we investigated the antiviral capacity of niclosamide against dengue virus (DENV) serotype 2 infection in vitro and in vivo. Principle finding: Niclosamide effectively retarded DENV-induced infection in vitro in human adenocarcinoma cells (A549), mouse neuroblastoma cells (Neuro-2a), and baby hamster kidney fibroblasts (BHK-21). Treatment with niclosamide did not retard the endocytosis of DENV while niclosamide was unable to enhance the antiviral type I interferon response. Furthermore, niclosamide did not cause a direct effect on viral replicon-based expression. Niclosamide has been reported to competitively inhibit the mTOR (mammalian target of rapamycin), STAT3 (signal transducer and activator of transcription 3), and NF-κB (nuclear factor kappa-light-chain-enhancer of activated B cells) signaling pathways; however, selective inhibitors of those pathways did not reduce DENV infection. Similar to the vacuolar-type H+-ATPase inhibitor bafilomycin A1, both niclosamide and other protonophores, such as CCCP (carbonyl cyanide m-chlorophenyl hydrazone), and FCCP (carbonyl cyanide-p-trifluoromethoxyphenylhydrazone), effectively reduced endosomal acidification and viral dsRNA replication. Co-administration of a single dose of niclosamide partially decreased viral replication, viral encephalitis, and mortality in DENV-infected ICR suckling mice. Significance: These results demonstrate that niclosamide diminishes viral infection by hindering endosomal acidification.",
author = "Kao, {Jo Chi} and HuangFu, {Wei Chun} and Tsai, {Tsung Ting} and Ho, {Min Ru} and Jhan, {Ming Kai} and Shen, {Ting Jing} and Tseng, {Po Chun} and Wang, {Yung Ting} and Lin, {Chiou Feng}",
year = "2018",
month = "8",
day = "1",
doi = "10.1371/journal.pntd.0006715",
language = "English",
volume = "12",
journal = "PLoS Neglected Tropical Diseases",
issn = "1935-2727",
publisher = "Public Library of Science",
number = "8",

}

TY - JOUR

T1 - The antiparasitic drug niclosamide inhibits dengue virus infection by interfering with endosomal acidification independent of mTOR

AU - Kao, Jo Chi

AU - HuangFu, Wei Chun

AU - Tsai, Tsung Ting

AU - Ho, Min Ru

AU - Jhan, Ming Kai

AU - Shen, Ting Jing

AU - Tseng, Po Chun

AU - Wang, Yung Ting

AU - Lin, Chiou Feng

PY - 2018/8/1

Y1 - 2018/8/1

N2 - Background: The antiparasitic agent niclosamide has been demonstrated to inhibit the arthropod-borne Zika virus. Here, we investigated the antiviral capacity of niclosamide against dengue virus (DENV) serotype 2 infection in vitro and in vivo. Principle finding: Niclosamide effectively retarded DENV-induced infection in vitro in human adenocarcinoma cells (A549), mouse neuroblastoma cells (Neuro-2a), and baby hamster kidney fibroblasts (BHK-21). Treatment with niclosamide did not retard the endocytosis of DENV while niclosamide was unable to enhance the antiviral type I interferon response. Furthermore, niclosamide did not cause a direct effect on viral replicon-based expression. Niclosamide has been reported to competitively inhibit the mTOR (mammalian target of rapamycin), STAT3 (signal transducer and activator of transcription 3), and NF-κB (nuclear factor kappa-light-chain-enhancer of activated B cells) signaling pathways; however, selective inhibitors of those pathways did not reduce DENV infection. Similar to the vacuolar-type H+-ATPase inhibitor bafilomycin A1, both niclosamide and other protonophores, such as CCCP (carbonyl cyanide m-chlorophenyl hydrazone), and FCCP (carbonyl cyanide-p-trifluoromethoxyphenylhydrazone), effectively reduced endosomal acidification and viral dsRNA replication. Co-administration of a single dose of niclosamide partially decreased viral replication, viral encephalitis, and mortality in DENV-infected ICR suckling mice. Significance: These results demonstrate that niclosamide diminishes viral infection by hindering endosomal acidification.

AB - Background: The antiparasitic agent niclosamide has been demonstrated to inhibit the arthropod-borne Zika virus. Here, we investigated the antiviral capacity of niclosamide against dengue virus (DENV) serotype 2 infection in vitro and in vivo. Principle finding: Niclosamide effectively retarded DENV-induced infection in vitro in human adenocarcinoma cells (A549), mouse neuroblastoma cells (Neuro-2a), and baby hamster kidney fibroblasts (BHK-21). Treatment with niclosamide did not retard the endocytosis of DENV while niclosamide was unable to enhance the antiviral type I interferon response. Furthermore, niclosamide did not cause a direct effect on viral replicon-based expression. Niclosamide has been reported to competitively inhibit the mTOR (mammalian target of rapamycin), STAT3 (signal transducer and activator of transcription 3), and NF-κB (nuclear factor kappa-light-chain-enhancer of activated B cells) signaling pathways; however, selective inhibitors of those pathways did not reduce DENV infection. Similar to the vacuolar-type H+-ATPase inhibitor bafilomycin A1, both niclosamide and other protonophores, such as CCCP (carbonyl cyanide m-chlorophenyl hydrazone), and FCCP (carbonyl cyanide-p-trifluoromethoxyphenylhydrazone), effectively reduced endosomal acidification and viral dsRNA replication. Co-administration of a single dose of niclosamide partially decreased viral replication, viral encephalitis, and mortality in DENV-infected ICR suckling mice. Significance: These results demonstrate that niclosamide diminishes viral infection by hindering endosomal acidification.

UR - http://www.scopus.com/inward/record.url?scp=85054854388&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85054854388&partnerID=8YFLogxK

U2 - 10.1371/journal.pntd.0006715

DO - 10.1371/journal.pntd.0006715

M3 - Article

AN - SCOPUS:85054854388

VL - 12

JO - PLoS Neglected Tropical Diseases

JF - PLoS Neglected Tropical Diseases

SN - 1935-2727

IS - 8

M1 - e0006715

ER -